Moderating and Presenting:
Jack Hoppin, PhD, CEO and Managing Director at Invicro to present:
TS24: 21st Century Nuclear Medicine: How Do We Realize its Full Potential?
Monday, June 12 | 3:00 – 4:30pm | Location: Mile High 4C (Colorado Convention Center)
Education: Technologist CE Session
Nuclear Medicine as a Research Tool in Translational Drug Discovery and Development | Jack Hoppin, PhD | 4:00 PM – 4:30 PM
John P. Seibyl, MD, Scientist and Managing Director at MNI, a Division of Invicro to present:
CE50: Read with the Experts: Dopamine Transporter Imaging
Monday, June 12 | 4:45 PM – 6:15 PM | Location: Mile High 1A-C (Colorado Convention Center)
Education: CE Session
Presentations: DAT imaging in Parkinsonism | John P Seibyl | 4:45 – 5:15 PM
SS50: New Approaches to Image Parkinson Syndrome
Tuesday, June 13 | 10:00 – 11:30 AM | Location: 704/706 (Colorado Convention Center) Room: 702/704/706 | No. 411
Education: Scientific CE Session
Four year Longitudinal Assessment of Scintigraphic Imaging Biomarkers in a Progressing Parkinson Disease Cohort | John P Seibyl | 10:00 AM
SS74: Novel Clinical Applications in Tauopathy and Epilepsy
Tuesday, June 13 | 4:45 – 6:15 PM | Location: 704/706 (Colorado Convention Center) | Room: 702/704/706
Education: Scientific CE Session
Initial Clinical PET Studies With The Novel Tau Agent 18-F PI-2620 In Alzheimer’s Disease And Controls | No. 630 | 5:25 PM